Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Harold C. Pillsbury is active.

Publication


Featured researches published by Harold C. Pillsbury.


Laryngoscope | 1997

A rationale for therapy of the N0 neck

Harold C. Pillsbury; Madison Clark

Perhaps there is no greater controversy in head and neck cancer than the proper treatment of the NO neck. It is well known that head and neck cancer is a locally aggressive disease that can cause great morbidity because of the inherent complexity of physiologic functions that take place in the head and neck (respiration, deglutination, olfaction, taste, speech, clearance of secretions, and so forth). Significant advances in the local-regional control, reconstruction, and rehabilitation of head and neck cancer patients have decreased local and regional morbidity (thereby preserving physiologic integrity), even in those who eventually succumb to distant metastasis. Despite these advances, including combined multimodality therapy, there has not been a corresponding increase in survival in the past 30 years.


Laryngoscope | 2004

Cochlear Implantation in Children with Congenital Inner Ear Malformations

Craig A. Buchman; Benjamin J. Copeland; Kathy K. Yu; Carolyn J. Brown; Vincent N. Carrasco; Harold C. Pillsbury

Objective/Hypothesis: To assess the audiologic and surgical outcomes for pediatric cochlear implant patients with inner ear malformations.


Ear and Hearing | 2007

Multicenter U.S. bilateral MED-EL cochlear implantation study: Speech perception over the first year of use

Emily Buss; Harold C. Pillsbury; Craig A. Buchman; Carol H. Pillsbury; Marcia S. Clark; David S. Haynes; Robert F. Labadie; Susan Amberg; Peter S. Roland; Pamela Kruger; Michael A. Novak; Julie A. Wirth; Jennifer M. Black; Robert W. Peters; Jennifer Lake; P. Ashley Wackym; Jill B. Firszt; Blake S. Wilson; Dewey T. Lawson; Reinhold Schatzer; Patrick S C D'Haese; Amy L. Barco

Objective: Binaural hearing has been shown to support better speech perception in normal-hearing listeners than can be achieved with monaural stimulus presentation, particularly under noisy listening conditions. The purpose of this study was to evaluate whether bilateral electrical stimulation could confer similar benefits for cochlear implant listeners. Design: A total of 26 postlingually deafened adult patients with short duration of deafness were implanted at five centers and followed up for 1 yr. Subjects received MED-EL COMBI 40+ devices bilaterally; in all but one case, implantation was performed in a single-stage surgery. Speech perception testing included CNC words in quiet and CUNY sentences in noise. Target speech was presented at the midline (0 degrees), and masking noise, when present, was presented at one of three simulated source locations along the azimuth (−90, 0, and +90 degrees). Results: Benefits of bilateral electrical stimulation were observed under conditions in which the speech and masker were spatially coincident and conditions in which they were spatially separated. Both the “head shadow” and “summation” effects were evident from the outset. Benefits consistent with “binaural squelch” were not reliably observed until 1 yr after implantation. Conclusions: These results support a growing consensus that bilateral implantation provides functional benefits beyond those of unilateral implantation. Longitudinal data suggest that some aspects of binaural processing continue to develop up to 1 yr after implantation. The squelch effect, often reported as absent or rare in previous studies of bilateral cochlear implantation, was present for most subjects at the 1 yr measurement interval.


Otology & Neurotology | 2002

Outcome of cochlear implantation in pediatric auditory neuropathy

Emily Buss; Robert F. Labadie; Carolyn J. Brown; Aimee J. Gross; John H. Grose; Harold C. Pillsbury

Objective Auditory neuropathy, characterized by absence or abnormality of auditory brainstem responses and normal otoacoustic emissions, is often associated with particularly poor response to amplification. Outcome data from four such pediatric patients who received cochlear implants are discussed. Study Design Four patients from the Carolina Childrens Communicative Disorders Program were identified as having received a diagnosis of auditory neuropathy before implantation with a Clarion cochlear implant. Speech data collected after implantation were compared with data from control pediatric implant patients, matched for age at implantation and duration of implant use. Electrically evoked auditory brainstem response data and electrically evoked acoustic reflex data were also obtained. Methods Routine clinical procedures were used to obtain speech outcome data. A 75-&mgr;s biphasic 21.1-Hz pulse train served as the eliciting stimulus for both evoked auditory brainstem responses and reflex measures, which were obtained contralateral to the implant. Results Speech data were comparable with those obtained from the general population of pediatric patients receiving cochlear implants at this center. Identifiable evoked auditory brainstem response data were obtained in all subjects on at least two of the three electrodes tested, and variability was comparable with that observed in other children with implants. A robust electrically evoked acoustic reflex with no decay was observed at estimated M-level in all children. Conclusion The data gathered to date suggest that the outcome of cochlear implantation in these four patients is not significantly different from that in other pediatric implant patients. Physiologic data suggest that the implant was able to overcome the desynchronization hypothesized to underlie auditory neuropathy.


Otolaryngology-Head and Neck Surgery | 2007

Asthma and the unified airway

John H. Krouse; Randall W. Brown; Stanley M. Fineman; Joseph K. Han; Andrew J. Heller; Stephanie A. Joe; Helene J. Krouse; Harold C. Pillsbury; Matthew W. Ryan

Inflammatory processes of the upper and lower airway commonly co-exist. Patients with upper respiratory illnesses such as allergic rhinitis and acute and chronic rhinosinusitis often present to both otolaryngologists and primary care physicians for treatment of their symptoms of nasal and sinus disease. These patients often have concurrent lower respiratory illnesses such as asthma that may be contributing to their overall symptoms and quality of life. Unfortunately, asthma frequently remains undiagnosed in this population. It was the objective of this paper to examine the relationship between upper respiratory illnesses such as rhinitis and rhinosinusitis and lower respiratory illnesses such as asthma, and to provide a framework for primary care and specialty physicians to approach these illnesses as a spectrum of inflammatory disease. The present manuscript was developed by a multidisciplinary workgroup sponsored by the American Academy of Otolaryngic Allergy. Health care providers in various specialties contributed to the manuscript through preparation of written materials and through participation in a panel discussion held in August 2006. Each author was tasked with reviewing a specific content area and preparing a written summary for inclusion in this final document. Respiratory inflammation commonly affects both the upper and lower respiratory tracts, often concurrently. Physicians who are treating patients with symptoms of allergic rhinitis and rhinosinusitis must be vigilant to the presence of asthma among these patients. Appropriate diagnostic methods should be used to identify individuals with concurrent respiratory illnesses, and comprehensive treatment should be instituted to reduce symptoms and improve quality of life.


Otolaryngology-Head and Neck Surgery | 1987

Part I. DNA Flow Cytometry as a Prognostic Indicator in Head and Neck Cancer

Manning M. Goldsmith; David H. Cresson; Larry A. Arnold; Duncan S. Postma; Frederic B. Askin; Harold C. Pillsbury

The prognostic significance of deoxyribonucleic acid (DNA) flow cytometry has been investigated for many solid tumors, but few data have been accumulated for squamous cell carcinomas of the head and neck. To our knowledge, we report the largest number of patients (69) with head and neck primary carcinomas to be studied by DNA flow cytometry. In the first part of this study, we reviewed 109 consecutive patients with laryngeal or hypopharyngeal primary carcinomas which were treated at North Carolina Memorial Hospital during the period of 1981 to 1984. The final analysis comprised 139 DNA histograms (mean coefficient of variation: 8.02) on paraffin-embedded specimens from 48 patients. Of the 48 patients with primary carcinomas, 24 had glottic, 18 had supraglottic, and 6 had carcinomas from the piriform sinus. Patients had follow-up for a minimum of 12 months, with a mean follow-up period of 23 months. Twenty-three of the 48 primary carcinomas (48%) were clearly aneuploid, and the remaining 52% were tetraploid (22%) or diploid (30%). We have concluded that patients with clearly aneuploid primary carcinomas had significantly better prognoses than those with diploid tumors (p = 0.008). High DNA amounts (greater than 40% of cells beyond the diploid peak, DNA G1GO) also correlated with a favorable prognosis when compared with low DNA amounts (p <0.01), and this remained significant when the clinical outcome was adjusted for staging of the primary site (T), nodal status, and stage of disease. Ploidy was the most significant prognostic variable for the laryngeal group of patients. In the second part of the study, twenty-one patients with oral cavity squamous cell carcinomas were studied in a similar fashion as the group with laryngeal carcinomas. In this group, a low DNA amount, with 40% as the cutoff point, was associated with a favorable prognosis (p = 0.024), and this remained significant while controlling for I, nodal status, and stage of disease. Numbers were too small to permit evaluation of the impact of ploidy in this group, but there was a slight trend toward aneuploidy and tetraploidy, correlating with a poor treatment outcome (p = 0.228). DNA amount was the most significant prognostic variable for the group of patients with oral cavity carcinomas. We conclude that DNA flow cytometry may be a powerful prognostic indicator in malignant conditions of the head and neck. The implications of these data for the management of head and neck cancer are discussed.


Otolaryngology-Head and Neck Surgery | 2000

Cochlear implant performance in senior citizens

Robert F. Labadie; Vincent N. Carrasco; Carol H. Gilmer; Harold C. Pillsbury

Cochlear implants are indicated for elderly patients with severe-to-profound hearing loss (sensorineural hearing loss ≥ 70 dB). Their use has been limited, possibly by the misconception that elderly patients will perform poorly. To document the performance of older adults (≥65 years old), we undertook a retrospective analysis of our postlingually deafened adult patients who underwent implantation with the CLARION Multi-Strategy Cochlear Implant and underwent formal audiologic analysis (sentence recognition [Central Institute for the Deaf, CID] and monosyllabic word recognition [consonant-noun-consonant, CNC]). Both younger (n = 20; mean age = 46.9 years) and older (n = 16; mean age = 71.5 years) adults showed statistically significant increases in CID and CNC scores after cochlear implantation. No statistically significant difference could be detected in operative time, anesthesia time, length of hospitalization, or CID or CNC scores between the two age groups. We conclude that age should not be a criterion for deciding who should receive cochlear implants. (Otolaryngol Head Neck Surg 2000;123:419-24.)


Laryngoscope | 1995

Insulin-dependent diabetic microangiopathy in the inner ear

Timothy L. Smith; Eileen M. Raynor; Jiri Prazma; John E. Buenting; Harold C. Pillsbury

Thickening of the basement membrane in capillaries is implicated in the microangiopathic complications of diabetes mellitus. This study was designed to evaluate microangiopathic changes of the inner ear associated with insulin‐dependent diabetes mellitus (IDDM) and concurrent moderate‐intensity noise exposure.


Laryngoscope | 2007

Scala tympani cochleostomy II: topography and histology.

Oliver F. Adunka; Andreas Radeloff; Wolfgang Gstoettner; Harold C. Pillsbury; Craig A. Buchman

Objective: To assess intracochlear trauma using two different round window‐related cochleostomy techniques in human temporal bones.


Hearing Research | 1994

Nitric oxide synthase is an active enzyme in the spiral ganglion cells of the rat cochlea

Carlton J. Zdanski; Jiri Prazma; Peter Petrusz; Gail Grossman; Eileen M. Raynor; Timothy L. Smith; Harold C. Pillsbury

Nitric oxide (NO) mediates the effects of the excitatory amino acids in the central nervous system. Excitatory amino acids, in particular L-glutamate, are thought to be the neurotransmitter(s) present at the cochlear hair cell-afferent nerve synapse. To our knowledge, no studies to date have documented the presence of NO in the cochlea nor attempted to elucidate the role of NO in hearing. Rat cochlea frozen sections were examined for the presence of nitric oxide synthase (NOS) by NADPH diaphorase histochemistry. Vibratome sections of rat cochlea were examined by immunocytochemistry with an antibody to citrulline, an indication of NOS activity. Spiral ganglion cells in the rat cochlea were positive by NADPH diaphorase histochemistry and by anti-citrulline immunocytochemistry. These results indicate that NOS is present and that the enzyme actively produces nitric oxide in the spiral ganglion cells of the rat cochlea. Given our current understanding of neurotransmission in the cochlea, it is reasonable to postulate that the actions of NO in cochlear neuronal tissue are similar to the actions of NO in the CNS and that NO acts as a neurotransmitter/neuromodulator in the cochlea. In addition, because NO has been implicated as a mediator of excitotoxicity in the CNS, NO may play a role in neurotoxicity in the cochlea.

Collaboration


Dive into the Harold C. Pillsbury's collaboration.

Top Co-Authors

Avatar

Jiri Prazma

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Craig A. Buchman

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Vincent N. Carrasco

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Oliver F. Adunka

The Ohio State University Wexner Medical Center

View shared research outputs
Top Co-Authors

Avatar

Joseph W. Hall

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

John H. Grose

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Emily Buss

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Margaret T. Dillon

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Carlton J. Zdanski

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Austin S. Rose

University of North Carolina at Chapel Hill

View shared research outputs
Researchain Logo
Decentralizing Knowledge